Videos

Recognizing Symptoms During Head and Neck Cancer Awareness Month

April 18th 2025, 8:00pm

Video

Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of the disease to be aware of.

Dr. Grivas Highlights Three Practice-Changing Trials in Bladder Cancer

April 17th 2025, 8:00pm

Video

Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three practice-changing phase 3 trials.

Raising Awareness on Multidisciplinary Approaches in GI Cancers

April 17th 2025, 1:00pm

Video

Patients with gastrointestinal cancer may benefit from multidisciplinary care and open communication with their care team, as per an expert.

Breaking Down The Use of Rina-S in Advanced Ovarian Cancer

April 16th 2025, 8:00pm

Video

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

Understanding Esophageal Cancer: Early Signs, Risks and Key Insights

April 16th 2025, 1:00pm

Video

Dr. Nataliya Uboha sat down to discuss the early warning signs of esophageal cancer, as well as important key takeaways for those with the disease.

Understanding How to Advance Immunotherapy Strategy Models in Melanoma

April 15th 2025, 8:00pm

Video

Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.

Radiation Therapy Advances Improve Quality of Life for GI Cancer

April 14th 2025, 8:00pm

Video

Advancements in radiation therapy, including proton therapy and stereotactic radiation, reduce side effects and improve quality of life for GI cancer.

Early Detection Critical for Testicular Cancer in Young Men

April 14th 2025, 1:02pm

Video

April serves as Testicular Cancer Awareness Month, which is the most common type of cancer in men aged between 15 and 44 years old.

Phase 3 Trial Leads to FDA Approval of Cabometyx in Neuroendocrine Tumors

April 13th 2025, 2:00pm

Video

Based on the phase 3 CABINET trial, the FDA approved Cabometyx for some patients with previously treated neuroendocrine tumors.

A Kidney Cancer Advocate Shares Advice for Newly Diagnosed Patients

April 11th 2025, 8:00pm

Video

Some cancer statistics may reflect 'backwards-looking data', making it important to stay up to date on reliable information and happenings in the space.